Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.91, $0.09 better than the analyst estimate of $0.82. Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE